DEXCOM INC Research And Development Expense

• DEXCOM INC showed an increase of +8.5% in Research And Development Expense from 2024 to 2025.
• This data is from DEXCOM INC's annual report (Form 10-K), filed with the SEC on February 12, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), DEXCOM INC's Research And Development Expense has grown by 4,091.3%.
• Historical annual values: Fiscal year 2025: $599.10 million | Fiscal year 2024: $552.40 million | Fiscal year 2023: $505.80 million | Fiscal year 2022: $484.20 million | Fiscal year 2021: $517.10 million | Fiscal year 2020: $359.90 million | Fiscal year 2019: $273.50 million | Fiscal year 2018: $199.70 million | Fiscal year 2017: $185.40 million | Fiscal year 2016: $156.10 million | Fiscal year 2015: $137.50 million | Fiscal year 2014: $69.40 million | Fiscal year 2013: $44.80 million | Fiscal year 2012: $38.30 million | Fiscal year 2011: $29.60 million | Fiscal year 2010: $23.20 million | Fiscal year 2009: $14.29 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026